Other Semaglutide Drugs Linked to Blood Clots Other semaglutide drugs, including Ozempic and Rybelsus, have also faced scrutiny over blood clots
I will tell you, in the phase three trials, anywhere from 8 to 15% of individuals in the trials so we know they're taking the drug do not lose at least 5% of their body weight
Bring current medications, relevant medical records, and specific questions about your goals
A: Some patients may experience mild nausea, constipation, or headaches as their body adjusts
Prescribing decisions should be individualised, considering the patient's specific needs, comorbidities, and treatment goals
Urinary tract infections (UTIs) are not among the primary adverse effects highlighted in published retatrutide trial data to date